Roads and detours for CAR T cell therapy in autoimmune diseases

Clinical Images: Sarcoidosis revealed by recurrent dactylitis

Efficacy of anifrolumab in lupus erythematous panniculitis: A retrospective study of 11 patients

CAR T-cell therapy in autoimmune diseases: where are we and where are we going?

CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future?

Efficacy of valaciclovir in preventing herpes zoster in patients receiving anifrolumab

CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?

Excess of infection with SARS-CoV-2 during the first versus second wave of the COVID-19 pandemic among patients with long COVID

The PP2A regulatory subunit PPP2R2A controls NAD(+) biosynthesis to regulate T cell subset differentiation in systemic autoimmunity

National committee statement as a missed opportunity to acknowledge the relevance of a biopsychosocial approach in understanding long COVID

CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses

Mind-body practices in chronic inflammatory arthritis

Correspondence on 'Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting'

The role of platelets in immune-mediated inflammatory diseases

Author Correction: The role of platelets in immune-mediated inflammatory diseases

Neurotransmitters arrive to control systemic autoimmunity

Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity

Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis

Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases

PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma

Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity

Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic

The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription

Role of stress in the development of rheumatoid arthritis: a case-control study

Reactive oxygen species: The Yin and Yang in (auto-)immunity

Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection

Shortage of aspartate in mitochondria fuels arthritis

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments

Ascorbate maintains a low plasma oxygen level

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

Discordance Between Patients and Physicians on Key Determinants of Systemic Lupus Erythematosus Burden: Insights From a French Comprehensive Survey

Systemic lupus pregnancies are characterized by an intrinsic pro-inflammatory monocyte transcriptome, driven by an aberrant miRNA signature

Advances in the treatment of systemic lupus erythematosus

Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus

French protocol for the diagnosis and management of systemic lupus erythematosus

Platelets are a major player and represent a therapeutic opportunity in systemic lupus erythematosus

Immunological and translational key challenges in systemic lupus erythematosus: A symposium update

New and future therapies: Changes in the therapeutic armamentarium for SLE

New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review

Difficulties and Psychological Impact of the SARS-CoV-2 Pandemic in Patients with Systemic Lupus Erythematosus: A Nationwide Patient Association Study

Role of Glutaminase 2 in Promoting CD4+ T Cell Production of Interleukin-2 by Supporting Antioxidant Defense in Systemic Lupus Erythematosus

Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

Reprogramming CAR T cells across genetic, epigenetic, metabolic and microenvironmental axes to improve efficacy and safety in cancer and autoimmune disease

Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event

Acute myocarditis after switching between two adalimumab biosimilars

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

Advancing medical training with augmented reality and haptic feedback simulator: outcomes of a randomized controlled trial on lumbar puncture

Reprogramming CAR T cells across genetic, epigenetic, metabolic and microenvironmental axes to improve efficacy and safety in cancer and autoimmune disease

Borrelia Infections Under B Cell-Depleting Therapies: A Systematic Review of Diagnostic Challenges and Outcomes With Special Focus on Neurological Forms

Borrelia Infections Under B Cell-Depleting Therapies: A Systematic Review of Diagnostic Challenges and Outcomes With Special Focus on Neurological Forms

Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study